Masimo (NASDAQ: MASI) has completed the sale of its Sound United consumer audio business to Harman International, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. The sale is part of Masimo's efforts to focus on its core professional healthcare business. Katie Szyman, the Chief Executive Officer of Masimo, expressed confidence in the company's ability to broaden its patient impact, accelerate growth, and deliver stronger margins following the completion of this transaction.
As a result of the sale, Masimo anticipates prioritizing share repurchases with the proceeds. Centerview Partners LLC and Morgan Stanley & Co. LLC served as financial advisors to Masimo, while Sullivan & Cromwell LLP served as the legal advisor in connection with the transaction.
Masimo, a global medical technology company, is known for developing and producing industry-leading monitoring technologies, including measurements, sensors, patient monitors, automation, and connectivity solutions. Its Masimo SET® measure-through motion and low perfusion™ pulse oximetry, introduced in 1995, has been shown to outperform other pulse oximetry technologies in over 100 independent and objective studies. This technology is estimated to be used on more than 200 million patients worldwide each year and is the primary pulse oximetry at all 10 top U.S. hospitals as ranked in the 2025 Newsweek World's Best Hospitals listing. The market has reacted to these announcements by moving the company's shares -0.84% to a price of $140.93. If you want to know more, read the company's complete 8-K report here.
